Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cornetta

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
British Journal of Haematology|April 1, 1992
Safety aspects of gene therapyK Cornetta
Gene Therapy|August 24, 1999
Rapid titer determination using quantitative real-time PCRN Sanburn, K Cornetta
Gene Therapy|February 15, 2001
Clinical retroviral vector production: step filtration using clinically approved filters improves titersL Reeves, K Cornetta
Journal of Clinical Apheresis|January 1, 1997
Retroviral gene therapy in hematopoietic diseasesK Cornetta, Y Fan
Experimental Hematology|April 1, 1983
Organ distribution of circulating very low density lipoproteins (VLDL): fate of hematopoietic growth inhibitory VLDL in the ratK Cornetta, S Zucker
Journal of Virological Methods|February 1, 1989
Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapyK Cornetta, W F Anderson
Human Gene Therapy|February 15, 2001
Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectorsJ Chen, L Reeves, K Cornetta
Human Gene Therapy|October 25, 2000
Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experienceL Reeves, P Smucker, K Cornetta
Gene Therapy|October 19, 2005
Retroviral vector production in the National Gene Vector Laboratory at Indiana UniversityK Cornetta, L Matheson, C Ballas
Progress in Nucleic Acid Research and Molecular Biology|January 1, 1989
Gene transfer into primates and prospects for gene therapy in humansK Cornetta, R Wieder, W F Anderson
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|April 1, 1992
Safety aspects of gene therapyK Cornetta
Gene Therapy|August 24, 1999
Rapid titer determination using quantitative real-time PCRN Sanburn, K Cornetta
Gene Therapy|February 15, 2001
Clinical retroviral vector production: step filtration using clinically approved filters improves titersL Reeves, K Cornetta
Journal of Clinical Apheresis|January 1, 1997
Retroviral gene therapy in hematopoietic diseasesK Cornetta, Y Fan
Experimental Hematology|April 1, 1983
Organ distribution of circulating very low density lipoproteins (VLDL): fate of hematopoietic growth inhibitory VLDL in the ratK Cornetta, S Zucker
Journal of Virological Methods|February 1, 1989
Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapyK Cornetta, W F Anderson
Human Gene Therapy|February 15, 2001
Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectorsJ Chen, L Reeves, K Cornetta
Human Gene Therapy|October 25, 2000
Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experienceL Reeves, P Smucker, K Cornetta
Gene Therapy|October 19, 2005
Retroviral vector production in the National Gene Vector Laboratory at Indiana UniversityK Cornetta, L Matheson, C Ballas
Progress in Nucleic Acid Research and Molecular Biology|January 1, 1989
Gene transfer into primates and prospects for gene therapy in humansK Cornetta, R Wieder, W F Anderson
Pageof 10